Product Information
AMOX-CLAV 250-125 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $1.5312 per EA under NDC 42571016030. Its NADAC has been published 469 times since Oct 11, 2017.
FDA first approved this application on Dec 30, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250; 125 mg/1; mg/1
Manufacturer
Micro Labs LimitedNDC
42571016030
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLIN; CLAVULANATE POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205707FDA Approved
12/30/2016
TE Code
AB
On Market Since
3/1/2017
Pharmacological Classes
Price Statistics
The NADAC for AMOX-CLAV 250-125 MG TABLET has been published 469 times since Oct 11, 2017, and over the history we have for it it has declined 47.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5312 per EA |
|---|---|
| All-time high | $4.1335 (Jun 13, 2018) |
| All-time low | $1.0579 (Nov 20, 2024) |
| 52-week high | $1.6389 |
| 52-week low | $1.4254 |
| Median price | $1.8549 |
| Average price | $2.1253 |
| Largest weekly change | +73.8% (Apr 21, 2021) |
| Weeks tracked | 469 |
| Tracking since | Oct 11, 2017 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin and Clavulanate Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOX-CLAV 250-125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 250-125 MG TABLET, manufactured by Micro Labs Limited, is $1.5312 per EA (NDC 42571016030), effective Sep 30, 2026.
How has the price of AMOX-CLAV 250-125 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMOX-CLAV 250-125 MG TABLET has declined 47.2%. It has been tracked across 469 weekly CMS publications since Oct 11, 2017.
What are the highest and lowest recorded NADAC prices for AMOX-CLAV 250-125 MG TABLET?
Since Oct 11, 2017, the NADAC for AMOX-CLAV 250-125 MG TABLET has ranged from a low of $1.0579 (Nov 20, 2024) to a high of $4.1335 (Jun 13, 2018), with a median of $1.8549 per EA.
Are there cheaper alternatives to AMOX-CLAV 250-125 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMOX-CLAV 250-125 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AMOX-CLAV 250-125 MG TABLET?
AMOX-CLAV 250-125 MG TABLET (NDC 42571016030) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.